NASDAQ : CELC
Celcuity Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 69.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.39B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 66.04M | 27.52M | 9.39M | 5.95M | 4.38M | 2.86M |
| Research & Development | 142.64M | 144.67M | 103.88M | 60.28M | 35.01M | 25.49M |
| Operating Expenses | 208.68M | 172.19M | 113.27M | 66.23M | 39.39M | 28.36M |
| Operating Income | -208.68M | -172.19M | -113.27M | -66.23M | -39.39M | -28.36M |
| Interest Expense | -22.27M | -17.15M | -10.28M | -5.33M | -2.11M | -1.26M |
| Interest & Investment Income | 15.94M | 12.30M | 11.77M | 7.78M | 1.13M | 13.26K |
| EBT Excluding Unusual Items | -215.00M | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M |
| Gain (Loss) on Sale of Assets | -263.00 | |||||
| Pretax Income | -226.48M | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M |
| Net Income | -226.48M | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M |
| Preferred Dividends & Other Adjustments | 272.00K | |||||
| Net Income to Common | -226.48M | -177.04M | -111.78M | -63.78M | -40.64M | -29.61M |
| Shares Outstanding (Basic) | 52.40M | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M |
| Shares Outstanding (Diluted) | 52.40M | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M |
| EPS (Basic) | -4.32 | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 |
| EPS (Diluted) | -4.32 | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 |
| Free Cash Flow | -192.16M | -153.53M | -83.72M | -53.91M | -36.17M | -20.39M |
| Free Cash Flow Per Share | -3.67 | -3.28 | -2.12 | -2.28 | -2.35 | -1.52 |
| EBITDA | -208.48M | -172.03M | -113.14M | -66.09M | -39.18M | -28.05M |
| D&A For EBITDA | 196.00K | 167.00K | 130.00K | 142.77K | 210.92K | 303.24K |
| EBIT | -208.68M | -172.19M | -113.27M | -66.23M | -39.39M | -28.36M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 182.05M | 165.70M | 22.52M | 30.66M | 24.57M | 84.29M |
| Short-Term Investments | 572.00M | 275.79M | 212.59M | 149.92M | 144.02M | 22.01K |
| Cash & Short-Term Investments | 754.04M | 441.50M | 235.10M | 180.58M | 168.59M | 84.31M |
| Other Receivables | 805.88K | 298.76K | ||||
| Receivables | 805.88K | 298.76K | ||||
| Prepaid Expenses | 13.00M | 18.90M | 6.77M | 8.92M | 722.68K | |
| Other Current Assets | 8.80M | 5.27M | 2.70M | 281.36K | 6.60M | 22.14K |
| Total Current Assets | 775.84M | 465.66M | 244.57M | 190.59M | 175.19M | 85.35M |
| Property, Plant & Equipment | 1.72M | 550.00K | 552.00K | 628.80K | 506.56K | 554.35K |
| Other Intangible Assets | 50.00M | 100.00K | ||||
| Other Long-Term Assets | 661.00K | 249.00K | ||||
| Total Assets | 828.22M | 466.56M | 245.12M | 191.22M | 175.70M | 85.91M |
| Accounts Payable | 8.09M | 6.41M | 9.37M | 5.08M | 2.63M | 1.51M |
| Accrued Expenses | 78.52M | 37.69M | 22.18M | 8.93M | 4.06M | 802.89K |
| Current Portion of Leases | 257.00K | 54.00K | 172.00K | 184.95K | 194.20K | 195.71K |
| Total Current Liabilities | 86.87M | 44.15M | 31.72M | 14.19M | 6.88M | 2.51M |
| Long-Term Debt | 753.24M | 321.85M | 97.73M | 37.04M | 34.98M | 14.63M |
| Long-Term Leases | 893.00K | 54.00K | 225.92K | 61.00K | 64.22K | |
| Total Liabilities | 841.00M | 366.00M | 129.50M | 51.45M | 41.93M | 17.20M |
| Common Stock | 49.00K | 48.00K | 37.00K | 25.51K | 21.67K | 14.92K |
| Additional Paid-In Capital | 567.77M | 549.40M | 387.44M | 299.82M | 230.05M | 124.62M |
| Retained Earnings | -580.60M | -448.90M | -271.86M | -160.08M | -96.30M | -55.93M |
| Total Common Equity | -12.78M | 100.56M | 115.62M | 139.77M | 133.77M | 68.71M |
| Shareholders' Equity | -12.78M | 100.56M | 115.62M | 139.77M | 133.77M | 68.71M |
| Total Liabilities & Equity | 828.22M | 466.56M | 245.12M | 191.22M | 175.70M | 85.91M |
| Total Debt | 754.38M | 321.90M | 97.95M | 37.45M | 35.24M | 14.89M |
| Net Cash (Debt) | -341.00K | 119.59M | 137.15M | 143.14M | 133.35M | 69.42M |
| Net Cash Per Share | -0.01 | 2.56 | 3.48 | 6.04 | 8.65 | 5.19 |
| Filing Date Shares Outstanding | 48.93M | 48.34M | 37.84M | 30.45M | 21.69M | 14.92M |
| Total Common Shares Outstanding | 48.92M | 48.24M | 37.14M | 25.51M | 21.67M | 14.92M |
| Working Capital | 688.97M | 421.51M | 212.85M | 176.40M | 168.31M | 82.85M |
| Book Value Per Share | -0.26 | 2.08 | 3.11 | 5.48 | 6.17 | 4.61 |
| Tangible Book Value | -62.78M | 100.45M | 115.62M | 139.77M | 133.77M | 68.71M |
| Tangible Book Value Per Share | -1.28 | 2.08 | 3.11 | 5.48 | 6.17 | 4.61 |
| Machinery | 2.66M | 2.33M | 1.79M | 1.68M | 1.52M | |
| Leasehold Improvements | 302.58K | 302.58K | 302.85K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -226.48M | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M |
| Depreciation & Amortization | 196.00K | 167.00K | 130.00K | 142.77K | 210.92K | 303.24K |
| Other Amortization | 4.51M | 3.14M | 1.33M | 241.75K | 395.76K | 267.82K |
| Loss (Gain) From Sale of Assets | 263.00 | |||||
| Stock-Based Compensation | 28.46M | 21.38M | 6.99M | 4.90M | 4.64M | 2.61M |
| Other Operating Activities | 12.46M | 1.73M | 1.51M | 821.50K | 308.90K | 5.29M |
| Change in Accounts Payable | -3.08M | -3.04M | 4.32M | 2.43M | 1.08M | 1.31M |
| Change in Other Net Operating Assets | -7.78M | 388.00K | 14.03M | 1.43M | -2.27M | -486.12K |
| Operating Cash Flow | -191.71M | -153.28M | -83.47M | -53.81M | -36.01M | -20.31M |
| Capital Expenditures | -450.00K | -249.00K | -250.00K | -97.64K | -158.77K | -81.90K |
| Sale of Property, Plant & Equipment | 500.00 | |||||
| Investment in Securities | -449.70M | -63.84M | -62.82M | -4.91M | -143.87M | |
| Investing Cash Flow | -450.27M | -64.08M | -63.07M | -5.01M | -144.03M | -81.40K |
| Long-Term Debt Issued | 231.25M | 61.66M | 19.51M | 14.35M | ||
| Long-Term Debt Repaid | -2.45K | -5.85K | -5.81K | |||
| Net Debt Issued (Repaid) | 651.65M | 231.25M | 61.66M | -2.45K | 19.50M | 14.34M |
| Issuance of Common Stock | 134.69M | 137.85M | 79.39M | 64.96M | 100.82M | 78.70M |
| Other Financing Activities | -8.66M | -8.55M | -2.67M | -48.52K | ||
| Financing Cash Flow | 777.67M | 360.55M | 138.39M | 64.91M | 120.33M | 93.04M |
| Net Cash Flow | 135.69M | 143.19M | -8.15M | 6.09M | -59.71M | 72.65M |
| Free Cash Flow | -192.16M | -153.53M | -83.72M | -53.91M | -36.17M | -20.39M |
| Free Cash Flow Per Share | -3.67 | -3.28 | -2.12 | -2.28 | -2.35 | -1.52 |
| Levered Free Cash Flow | -72.00M | -96.05M | -50.93M | -35.62M | -22.03M | -14.63M |
| Unlevered Free Cash Flow | -62.60M | -88.47M | -45.84M | -32.54M | -21.11M | -14.11M |
| Cash Interest Paid | 14.99M | 10.35M | 7.59M | 3.27M | 1.26M | 694.53K |
| Change in Working Capital | -10.86M | -2.65M | 18.35M | 3.86M | -1.19M | 819.81K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.38B | 4.62B | 486.03M | 367.71M | 303.56M | 196.78M |
| Enterprise Value | 3.38B | 4.48B | 319.16M | 270.74M | 261.37M | 121.13M |
| Last Close Price | 69.13 | 99.74 | 13.09 | 14.57 | 14.01 | 13.19 |
| PB Ratio | 45.90 | 4.20 | 2.63 | 2.27 | 2.86 | |
| P/TBV Ratio | 45.94 | 4.20 | 2.63 | 2.27 | 2.86 | |
| Debt / Equity Ratio | -59.02 | 3.20 | 0.85 | 0.27 | 0.26 | 0.22 |
| Net Debt / Equity Ratio | -0.03 | -1.19 | -1.19 | -1.02 | -1.00 | -1.01 |
| Net Debt / EBITDA Ratio | -0.00 | 0.69 | 1.21 | 2.17 | 3.40 | 2.48 |
| Net Debt / FCF Ratio | -0.00 | 0.78 | 1.64 | 2.65 | 3.69 | 3.40 |
| Quick Ratio | 8.68 | 10.00 | 7.41 | 12.78 | 24.50 | 33.77 |
| Current Ratio | 8.93 | 10.55 | 7.71 | 13.43 | 25.46 | 34.06 |
| Return on Equity (ROE) | -1,433.70% | -163.80% | -87.54% | -46.63% | -39.88% | -73.63% |
| Return on Assets (ROA) | -25.78% | -30.24% | -32.45% | -22.56% | -18.82% | -35.85% |
| Return on Capital Employed (ROCE) | -28.10% | -40.80% | -53.10% | -37.40% | -23.30% | -34.00% |
| Earnings Yield | -6.25% | -3.84% | -23.00% | -17.34% | -13.30% | -15.04% |
| FCF Yield | -5.68% | -3.33% | -17.22% | -14.66% | -11.91% | -10.36% |
| Buyback Yield / Dilution | -21.53% | -18.53% | -66.60% | -53.58% | -15.21% | -30.35% |